A randomised, double-blind, placebo-controlled study to evaluate the safety and efficacy of lamotrigine in the maintenance treatment of Chinese adult patients with bipolar I disorder

BACKGROUND: Lamotrigine is approved as a maintenance therapy for bipolar I disorder in many countries, including China in 2021. This study evaluated the efficacy and safety of lamotrigine in controlling relapse and/or recurrence of mood episodes in Chinese patients with bipolar I disorder. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Ling, Zhang, Honggeng, Lv, Lu-xian, Tan, Qingrong, Xu, Xiufeng, Hu, Jian, Zi, Lu, Cooper, James, Phansalkar, Abhay, Wang, Gang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9339436/
https://www.ncbi.nlm.nih.gov/pubmed/35909213
http://dx.doi.org/10.1186/s40345-022-00266-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9339436/
https://www.ncbi.nlm.nih.gov/pubmed/35909213
http://dx.doi.org/10.1186/s40345-022-00266-4

Ejemplares similares